Effects of switching statins on achievement of lipid goals: measuring effective reductions in cholesterol using rosuvastatin therapy (MERCURY I) study
Open Access
- 1 April 2004
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 147 (4), 705-712
- https://doi.org/10.1016/j.ahj.2003.10.004
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR**STELLAR = Statin Therapies for Elevated Lipid Levels compared Across doses to Rosuvastatin. Trial)The American Journal of Cardiology, 2003
- Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groupsThe American Journal of Cardiology, 2003
- Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goalsThe American Journal of Cardiology, 2003
- Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: A randomized, double-blind, 52-week trialAmerican Heart Journal, 2002
- Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemiaAmerican Heart Journal, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Additional Efficacy of Milligram-Equivalent Doses of Atorvastatin over SimvastatinClinical Drug Investigation, 2000
- The Lipid Treatment Assessment Project (L-TAP)Archives of Internal Medicine, 2000
- Prevention of coronary heart disease in clinical practice Recommendations of the Second Joint Task Force of European and other Societies on Coronary PreventionEuropean Heart Journal, 1998
- Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.The American Journal of Cardiology, 1998